دسترسی نامحدود
برای کاربرانی که ثبت نام کرده اند
برای ارتباط با ما می توانید از طریق شماره موبایل زیر از طریق تماس و پیامک با ما در ارتباط باشید
در صورت عدم پاسخ گویی از طریق پیامک با پشتیبان در ارتباط باشید
برای کاربرانی که ثبت نام کرده اند
درصورت عدم همخوانی توضیحات با کتاب
از ساعت 7 صبح تا 10 شب
ویرایش: [2nd ed. 2023] نویسندگان: Harry W. Flynn Jr., Nidhi Relhan Batra, Stephen G. Schwartz, Prashanth G. Iyer, Lyubomyr Lytvynchuk, Andrzej Grzybowski سری: ISBN (شابک) : 3031351835, 9783031351839 ناشر: Springer سال نشر: 2023 تعداد صفحات: 244 [235] زبان: English فرمت فایل : PDF (درصورت درخواست کاربر به PDF، EPUB یا AZW3 تبدیل می شود) حجم فایل: 10 Mb
در صورت تبدیل فایل کتاب Endophthalmitis in Clinical Practice به فرمت های PDF، EPUB، AZW3، MOBI و یا DJVU می توانید به پشتیبان اطلاع دهید تا فایل مورد نظر را تبدیل نمایند.
توجه داشته باشید کتاب اندوفتالمیت در عمل بالینی نسخه زبان اصلی می باشد و کتاب ترجمه شده به فارسی نمی باشد. وبسایت اینترنشنال لایبرری ارائه دهنده کتاب های زبان اصلی می باشد و هیچ گونه کتاب ترجمه شده یا نوشته شده به فارسی را ارائه نمی دهد.
این کتاب یک راهنمای مختصر و کاربردی برای مدیریت اندوفتالمیت برای پزشکان پر مشغله چشم ارائه می دهد. این شامل بسیاری از نکات، ترفندها، مرواریدهای بالینی و عکس های رنگی برای نشان دادن جنبه های مختلف تشخیص است که می توان به سرعت در هنگام ارزیابی بیماران به آنها اشاره کرد. Endophthalmitis در عمل بالینی، ویرایش دوم از یک سبک «کتاب آشپزی» استفاده میکند تا اطمینان حاصل شود که اطلاعات میتواند به سرعت و کارآمد برای بهترین مراقبت ممکن از بیماران مبتلا به اندوفتالمیت به دست آید. علاوه بر سبک نگارش مختصر، اندازه جمع و جور این کتاب به این معنی است که می توان آن را در یک کیف آماده نگه داشت و در عمل بالینی به راحتی با آن مشورت کرد. موضوعات جدید در این ویرایش دوم شامل نقش آنتی بیوتیک های سیستمیک، استروئیدها در مدیریت اندوفتالمیت، التهاب غیر عفونی، ویترکتومی آندوسکوپی و همچنین به روز رسانی در مورد اندوفتالمیت مرتبط با کراتیت عفونی از جمله نقش درمان فتودینامیک و تشخیص میکروبی است.
This book provides a concise, practical guide to the management of endophthalmitis for busy ophthalmic clinicians. It includes many tips, tricks, clinical pearls and colour photographs to illustrate various aspects of diagnosis that can be quickly referred to when assessing patients. Endophthalmitis in Clinical Practice, 2nd Edition utilises an easy-to-follow ‘cookbook’ style to ensure that information can be rapidly and efficiently obtained for the best possible care of patients with endophthalmitis. In addition to the concise writing style, the compact size of this book means that it can be kept in an on-call bag and can be easily consulted to in clinical practice. New topics in this second edition include the role of systemic antibiotics, steroids in the management of endophthalmitis, non-infectious inflammation, endoscopic vitrectomy as well as updates on infectious keratitis associated endophthalmitis including the roles of photodynamic therapy and microbial diagnostics.
Foreword Conflict of Interest Endophthalmitis How to Use This Book Contents Chapter 1: Endophthalmitis: Classification and Most Frequently Reported Organisms Chapter 2: Differential Diagnosis of Endophthalmitis Toxic Anterior Segment Syndrome (Fig. 2.1) Retained Lens Fragments (Figs. 2.2 and 2.3) Flare-Up of Pre-existing Uveitis Vitreous Hemorrhage Retinoblastoma Uveal Melanoma Intravitreal Triamcinolone Acetonide Viral Retinitis Noninfectious Inflammation from Intravitreal Injections Brolucizumab-Related Intraocular Inflammation Drug-Associated Uveitis (a Rare Cause of Pseudoendophthalmitis) Chapter 3: Diagnosis of Endophthalmitis: Clinical Presentation, Pathology, Microbiology, and Echography Clinical Presentations Microbiology How to Perform TAP and Inject Intravitreal Antimicrobial Injection Results of Anterior Chamber TAP Versus Vitreous TAP Culture Media Other Testing Echography Chapter 4: Acute-Onset Endophthalmitis: Clinical Categories, Incidence Rates, Signs/Symptoms, Risk Factors, Microbiology, Treatment, and Follow-Up Acute-Onset Post-Operative Endophthalmitis Following Cataract Surgery Incidence Signs/Symptoms Risk Factors Microbial Isolates Initial Management of Acute-Onset Post-Operative Endophthalmitis Intravitreal antimicrobials (Fig. 4.5) Follow-Up Management of Acute-Onset Post-Operative Endophthalmitis (Fig. 4.6) First Morning after Initial Treatment Two to Three Days after Initial Treatment Acute-Onset Endophthalmitis Following Pars Plana Vitrectomy Incidence Signs/Symptoms Risk Factors (Table 4.1) Microbial Isolates Endophthalmitis after Pars Plana Vitrectomy for Vitreous Floaters (Fig. 4.7) Initial Management of Acute-Onset Endophthalmitis Following Vitrectomy Follow-Up Management in Patients with Acute-Onset Endophthalmitis Following Vitrectomy First Morning after Initial Treatment Two to Three Days after Initial Treatment Post-Traumatic Endophthalmitis Incidence Signs/Symptoms Risk Factors Microbial Isolates Initial Management of Post-Traumatic Endophthalmitis Follow-Up Management in Patients with Post-Traumatic Endophthalmitis First Morning after Initial Treatment Two to Three Days after Initial Treatment Endophthalmitis Associated with Intravitreal Injection Incidence Signs/Symptoms of Endophthalmitis after Intravitreal Injections Risk Factors Microbial Isolates Initial Management of Endophthalmitis Associated with Intravitreal Injection Follow-Up Management in Patients with Endophthalmitis Associated with Intravitreal Injection First Morning after Initial Treatment Two to Three Days after Initial Treatment Additional Discussion Points Vitreous TAP Versus AC TAP/Paracentesis Controversies in Care Systemic Immunosuppressives and the Risk of Post-Cataract Surgery Endophthalmitis Chapter 5: Delayed-Onset (Chronic) Endophthalmitis and Miscellaneous Categories: Incidence Rates, Signs/Symptoms, Risk Factors, Microbiology, Treatment, and Follow-Up Delayed-Onset (Chronic) Post-Operative Endophthalmitis Following Cataract Surgery Incidence Signs/Symptoms Risk Factors Microbial Isolates Initial Management of Delayed-Onset Endophthalmitis Follow-Up Management in Patients with Delayed-Onset Post-Operative Endophthalmitis First Morning after Initial Treatment Two to Three Days after Initial Treatment Conjunctival Filtering Bleb: Associated Infection and Endophthalmitis Incidence of Bleb-Associated Endophthalmitis Signs/Symptoms Risk Factors Microbial Isolates Initial Management of Conjunctival Filtering Bleb-Associated Endophthalmitis Follow-Up Management in Patients with Conjunctival Filtering Bleb-Associated Infection or Endophthalmitis First Morning after Initial Treatment Two to Three Days after Initial Treatment Endophthalmitis Associated with Glaucoma Drainage Devices Incidence Signs/Symptoms Risk Factors Microbiology Initial Management of Glaucoma Drainage Device-Associated Endophthalmitis Follow-Up Management in Patients with Endophthalmitis Associated with Glaucoma Drainage Devices First Morning after Initial Treatment Two to Three Days after Initial Treatment Delayed-Onset Endophthalmitis Associated with Keratitis Incidence Signs/Symptoms Risk Factors for Keratitis that May Lead to Endophthalmitis Microbial Isolates Initial Management of Endophthalmitis Associated with Keratitis Follow-Up Management in Patients with Endophthalmitis Associated with Keratitis First Morning after Initial Treatment Two to Three Days after Initial Treatment The Role of Corneal Collagenous Cross-Linking (CXL) in the Treatment of Keratitis and Corneal Ulcers The Role of Photodynamic Therapy in Advanced Keratitis with Threat of Endophthalmitis Endophthalmitis after Pterygium Removal Endophthalmitis After Strabismus Surgery Endophthalmitis Post-Suture Removal Endophthalmitis after Blepharoplasty (Fig. 5.14) Chapter 6: Endogenous Endophthalmitis: Incidence Rates, Signs/Symptoms, Risk Factors, Microbiology, Treatment, and Follow-Up Endogenous Fungal Endophthalmitis Incidence Signs/Symptoms Risk Factors Malignancy Microbial Isolates Initial Management of Endogenous Fungal Endophthalmitis Follow-Up Management in Patients with Endogenous Fungal Endophthalmitis First Morning After Initial Treatment (Based on Clinical Examination) Two to Three Days After Initial Treatment (Based on Clinical Examination) Screening of Endogenous Candida Endophthalmitis in the Hospital Setting Endogenous Bacterial Endophthalmitis Incidence Signs/Symptoms Risk Factors Malignancy Microbial Isolates Initial Management of Endogenous Bacterial Endophthalmitis Follow-Up Management in Patients with Endogenous Bacterial Endophthalmitis. First Morning After Initial Treatment (Based on Clinical Exam). Two to Three Days After Initial Treatment (Based on Clinical Exam). Chapter 7: Pars Plana Vitrectomy for the Management of Endophthalmitis: Endophthalmitis Vitrectomy Study and Beyond Endophthalmitis Vitrectomy Study Early Vitrectomy for Endophthalmitis (beyond the EVS) Endophthalmitis in Phakic Eyes Endoscopic Vitrectomy for Endophthalmitis Chapter 8: Antimicrobial Treatment, Resistance, and Alternatives Antimicrobial Routes Summary of Antimicrobial Dosages (Table 8.1) Preparation of Antimicrobials Preparation of Intravitreal Antimicrobials (Table 8.2) Preparation of Subconjunctival Antibiotics (Table 8.3) Preparation of Fortified Topical Antimicrobials (Table 8.4) Adverse Effects of Antimicrobials Antimicrobial Resistance and Alternatives Data on Antimicrobial Resistance Pharmacokinetics and Pharmacodynamics of Antimicrobials Chapter 9: Endophthalmitis Prophylaxis Antisepsis Topical Antibiotics Topical Antibiotics: Literature Systemic Antibiotics Endophthalmitis Prophylaxis for Specific Case Scenarios Endophthalmitis Prophylaxis for Cataract Surgery Corneal Wound Closure Endophthalmitis Prophylaxis for Intravitreal Injections Endophthalmitis Prophylaxis for Open Globe Injuries Chapter 10: Retinal Detachment (RD) and Endophthalmitis Frequency: Retinal Detachment in Endophthalmitis Visual Outcomes: Retinal Detachment in Endophthalmitis Presentation: Retinal Detachment in Endophthalmitis Risk Factors Associated with Poor Visual Outcomes in Eyes with RD and Endophthalmitis Role of Silicone Oil in Endophthalmitis Patients (Fig. 10.1) Hyperoleon Antimicrobial Properties of Silicone Oil Literature: Silicone Oil in Endophthalmitis and Rhegmatogenous Retinal Detachment Chapter 11: Antibiotic Stewardship Chapter 12: Outcomes (Anatomic and Functional) and Treatment-Related Complications Treatment Outcomes of Acute-Onset Post-Operative Endophthalmitis Following Cataract Surgery Outcomes as Reported by the EVS Lalwani et al. 2008 Yannuzzi et al. 2016 Treatment Outcomes of Delayed-Onset Post-Operative Endophthalmitis Following Cataract Surgery Clark et al. Shirodkar et al. (2012) Treatment Outcomes of Endophthalmitis after Pars Plana Vitrectomy Treatment Outcomes of Endophthalmitis Following Glaucoma Surgery Conjunctival Filtering Bleb-Associated Infection and Endophthalmitis Leng et al. (2011) Endophthalmitis Associated with Glaucoma Drainage Devices Medina et al. (2016) Treatment Outcomes of Post-Traumatic Endophthalmitis Colyer et al. (Ophthalmology 2007) Mieler et al. (Ophthalmology 1990) Banker et al. (OSLI Retina, 2017) Treatment Outcomes of Endogenous Endophthalmitis Schiedler et al. (2004) Lingappan et al. (2012) Sridhar et al. (2013) Treatment Outcomes of Endophthalmitis Associated with Intravitreal Injection Goldberg et al. (Ophthalmology 2013) Gregori et al. (Retina 2015) Yannuzzi et al. (OSLI-Retina 2018) Complications Associated with Endophthalmitis Prophylaxis/Treatment